Jayson Donald Alexander Dallas Insider Trading $RARE Ultragenyx Pharmaceutical Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jayson Donald Alexander Dallas.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jayson Donald Alexander Dallas. Jayson Donald Alexander Dallas is Director in ARENA PHARMACEUTICALS INC ($ARNA) and EVP & Chief Commercial Officer in Ultragenyx Pharmaceutical Inc. ($RARE) and See Remarks in Ultragenyx Pharmaceutical Inc. ($RARE) and President and CEO in Aimmune Therapeutics, Inc. ($AIMT).
Jayson Donald Alexander Dallas in Ultragenyx Pharmaceutical Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Jayson Donald Alexander Dallas: EVP & Chief Commercial Officer, See Remarks
Holdings: 23,830 shares
Current Value: $1,737,445
Latest Transaction: Jun 04 2018
$RARE Market Capitalization: $2.92B
$RARE Previous Close: $72.91
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Jayson Donald Alexander Dallas in Ultragenyx Pharmaceutical Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AIMT, ARNA, RARE
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 04 2018 | RARE | Ultragenyx Pharmac ... | Dallas Jayson Donald Alexander | EVP & Chief Commerc ... | Payment of Exercise | F | 73.73 | 294 | 21,677 | 23,830 | 24.1 K to 23.8 K (-1.22 %) |
| Apr 19 2018 | RARE | Ultragenyx Pharmac ... | Dallas Jayson Donald Alexander | EVP & Chief Commerc ... | Grant | A | 0.00 | 1,431 | 0 | 23,604 | 22.2 K to 23.6 K (+6.45 %) |
| Mar 05 2018 | RARE | Ultragenyx Pharmac ... | Dallas Jayson Donald Alexander | EVP & Chief Commerc ... | Option Exercise | A | 48.43 | 32,000 | 1,549,760 | 32,000 | |
| Mar 05 2018 | RARE | Ultragenyx Pharmac ... | Dallas Jayson Donald Alexander | EVP & Chief Commerc ... | Payment of Exercise | F | 48.43 | 441 | 21,358 | 22,173 | 22.6 K to 22.2 K (-1.95 %) |
| Mar 05 2018 | RARE | Ultragenyx Pharmac ... | Dallas Jayson Donald Alexander | EVP & Chief Commerc ... | Grant | A | 0.00 | 6,500 | 0 | 22,614 | 16.1 K to 22.6 K (+40.34 %) |
| Aug 07 2017 | RARE | Ultragenyx Pharmac ... | Dallas Jayson Donald Alexander | EVP & Chief Commerc ... | Payment of Exercise | F | 62.59 | 940 | 58,835 | 16,107 | 17 K to 16.1 K (-5.51 %) |
| Jun 01 2017 | RARE | Ultragenyx Pharmac ... | Dallas Jayson Donald Alexander | EVP & Chief Commerc ... | Payment of Exercise | F | 56.61 | 320 | 18,115 | 17,047 | 17.4 K to 17 K (-1.84 %) |
| Mar 01 2017 | RARE | Ultragenyx Pharmac ... | Dallas Jayson Donald Alexander | EVP & Chief Commerc ... | Option Exercise | A | 88.80 | 30,000 | 2,664,000 | 30,000 | |
| Mar 01 2017 | RARE | Ultragenyx Pharmac ... | Dallas Jayson Donald Alexander | EVP & Chief Commerc ... | Grant | A | 0.00 | 4,500 | 0 | 16,960 | 12.5 K to 17 K (+36.12 %) |
| Aug 08 2016 | RARE | Ultragenyx Pharmac ... | Dallas Jayson Donald Alexander | See Remarks | Payment of Exercise | F | 64.24 | 940 | 60,386 | 12,460 | 13.4 K to 12.5 K (-7.01 %) |
| Jun 07 2016 | RARE | Ultragenyx Pharmac ... | Dallas Jayson Donald Alexander | See Remarks | Option Exercise | A | 69.53 | 11,000 | 764,830 | 11,000 | |
| Jun 03 2016 | RARE | Ultragenyx Pharmac ... | Dallas Jayson Donald Alexander | See Remarks | Option Exercise | A | 70.57 | 20,200 | 1,425,514 | 20,200 | |
| Jun 03 2016 | RARE | Ultragenyx Pharmac ... | Dallas Jayson Donald Alexander | See Remarks | Grant | A | 0.00 | 3,400 | 0 | 13,400 | 10 K to 13.4 K (+34.00 %) |
| Aug 06 2015 | RARE | Ultragenyx Pharmac ... | Dallas Jayson Donald Alexander | See Remarks | Option Exercise | A | 116.45 | 90,000 | 10,480,500 | 90,000 | |
| Aug 06 2015 | RARE | Ultragenyx Pharmac ... | Dallas Jayson Donald Alexander | See Remarks | Grant | A | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
Page: 1